Australia markets close in 2 hours 24 minutes

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.0400-0.2600 (-7.88%)
At close: 04:00PM EDT
3.0500 +0.01 (+0.33%)
After hours: 07:55PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts8888
Avg. Estimate-0.6-0.55-2.33-1.07
Low estimate-0.65-0.66-2.61-2.96
High estimate-0.46-0.36-1.790.49
Year ago EPS-0.530.72-0.72-2.33
Revenue estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts7778
Avg. Estimate4.98M7.77M19.87M152.77M
Low estimate1.25M1.25M5.24M40M
High estimate11.13M20M35M318.6M
Year ago salesN/A126.72M144.93M19.87M
Sales growth (year/est)N/A-93.90%-86.30%668.80%
Earnings history29/06/202129/09/202130/12/202130/03/2022
Est. EPS-0.37-0.46-0.44-0.52
Actual EPS-0.530.72-0.52-0.61
Difference-0.161.18-0.08-0.09
Surprise %-43.20%256.50%-18.20%-17.30%
EPS trendCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Current estimate-0.6-0.55-2.33-1.07
7 days ago-0.6-0.55-2.32-1.08
30 days ago-0.53-0.48-1.89-1.15
60 days ago-0.53-0.48-1.89-1.15
90 days ago-0.57-0.56-1.8-1.45
EPS revisionsCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/A11
Up last 30 days2323
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A1N/A
Growth estimatesMCRBIndustrySector(s)S&P 500
Current qtr.-13.20%N/AN/AN/A
Next qtr.-176.40%N/AN/AN/A
Current year-223.60%N/AN/AN/A
Next year54.10%N/AN/AN/A
Next 5 years (per annum)-134.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A